SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-155623
Filing Date
2021-05-10
Accepted
2021-05-10 07:31:15
Documents
61
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d128670d10q.htm   iXBRL 10-Q 1108446
2 EX-31.1 d128670dex311.htm EX-31.1 6911
3 EX-31.2 d128670dex312.htm EX-31.2 6331
4 EX-32 d128670dex32.htm EX-32 4738
  Complete submission text file 0001193125-21-155623.txt   6102511

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA itci-20210331.xsd EX-101.SCH 42216
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE itci-20210331_cal.xml EX-101.CAL 36373
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itci-20210331_def.xml EX-101.DEF 259902
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE itci-20210331_lab.xml EX-101.LAB 401954
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itci-20210331_pre.xml EX-101.PRE 368464
10 EXTRACTED XBRL INSTANCE DOCUMENT d128670d10q_htm.xml XML 1075234
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36274 | Film No.: 21905246
SIC: 2834 Pharmaceutical Preparations